An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes. 

 - 1 online resource ([86] pages) 
<br/><br/> "Aug. 18, 2017 (H.R. 2430)."  "131 Stat. 1005."  "Public Law 115-52."  CRDP Program record. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs--Prices--Law and legislation--United States.<br/>Prescription pricing--Law and legislation--United States.<br/>Medical instruments and apparatus industry--Law and legislation--United States.<br/>Generic drugs--Prices--United States.<br/>Biologicals--Law and legislation--United States.<br/>User charges--Law and legislation--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Statutes and codes.
<br/><br/><label>GPO Item No.: </label>0575-A-02 (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>AE 2.110:115-52 
<br/><br/><label>Report. No.: </label>Public Law 115-52